SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biophan Technologies, Inc. was Issued Two New U.S. Patents
BIPH 16.60+0.3%Jan 9 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10PreviousNext  
To: Gabi who wrote (9)12/7/2005 11:48:31 PM
From: 9wald9   of 10
 
In addition to the established technologies for which Biophan announced these forecasts, Biophan also continues development of a long-term product pipeline of technologies such as a novel biothermal power supply and controlled drug delivery methods. The Company is jointly developing the biothermal power source with NASA's Ames Research Center. The power supply is designed to generate power from a patient's natural body heat, and to replace and/or augment traditional batteries in implanted devices.The Company is also working to adapt its nanomagnetic particle technology to produce novel MRI contrast agents and
controlled drug delivery materials. These technologies are still in early development stages, and no forecasts have been provided related to their commercialization.
Nov.21, 2005 PR in part

BIPH
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10PreviousNext